141 related articles for article (PubMed ID: 20663136)
21. Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study.
Chavez-Blanco A; Segura-Pacheco B; Perez-Cardenas E; Taja-Chayeb L; Cetina L; Candelaria M; Cantu D; Gonzalez-Fierro A; Garcia-Lopez P; Zambrano P; Perez-Plasencia C; Cabrera G; Trejo-Becerril C; Angeles E; Duenas-Gonzalez A
Mol Cancer; 2005 Jul; 4(1):22. PubMed ID: 16001982
[TBL] [Abstract][Full Text] [Related]
22. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M
J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963
[TBL] [Abstract][Full Text] [Related]
23. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
[TBL] [Abstract][Full Text] [Related]
24. [Putrescine in evaluation of the leukemic process in children].
Kovtunova ME; Riabova TI
Gematol Transfuziol; 1991 Jan; 36(1):26-8. PubMed ID: 2065942
[TBL] [Abstract][Full Text] [Related]
25. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.
Park YS; Jin MY; Kim YJ; Yook JH; Kim BS; Jang SJ
Ann Surg Oncol; 2008 Jul; 15(7):1968-76. PubMed ID: 18470569
[TBL] [Abstract][Full Text] [Related]
26. Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
Li XY; Li JQ; Luo XQ; Wu XD; Sun X; Xu HG; Li CG; Liu RY; Sun XF; Chen HQ; Lin YD; Li CK; Fang JP
BMC Cancer; 2021 Jan; 21(1):59. PubMed ID: 33435902
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcome of hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL): experience from a single institution.
Doki N; Ohashi K; Oshikawa G; Kobayashi T; Kakihana K; Sakamaki H
Pathol Oncol Res; 2014 Jan; 20(1):61-6. PubMed ID: 23821455
[TBL] [Abstract][Full Text] [Related]
28. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
29. Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia.
Faderl S; Thall PF; Kantarjian HM; Talpaz M; Harris D; Van Q; Beran M; Kornblau SM; Pierce S; Estrov Z
Clin Cancer Res; 1999 Dec; 5(12):4041-7. PubMed ID: 10632337
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of Clinical Outcomes between P190 and P210 Trans-cripts in Adult Ph Chromosome Positive Acute Lymphoblastic Leukemia in the New Era of TKI].
Qiu LL; Lu YJ; Jing Y; Yu L; Liu DH; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):369-74. PubMed ID: 27150994
[TBL] [Abstract][Full Text] [Related]
31. Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
Gandemer V; Auclerc MF; Perel Y; Vannier JP; Le Gall E; Demeocq F; Schmitt C; Piguet C; Stephan JL; Lejars O; Debre M; Jonveaux P; Cayuela JM; Chevret S; Leverger G; Baruchel A;
BMC Cancer; 2009 Jan; 9():14. PubMed ID: 19144139
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
[TBL] [Abstract][Full Text] [Related]
33. ZAP-70 as a possible prognostic factor in childhood acute lymphoblastic leukemia.
Ebeid E; Kamel M; Moussa H; Galal U
J Egypt Natl Canc Inst; 2008 Jun; 20(2):121-6. PubMed ID: 20029467
[TBL] [Abstract][Full Text] [Related]
34. Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
Schroeder H; Garwicz S; Kristinsson J; Siimes MA; Wesenberg F; Gustafsson G
Med Pediatr Oncol; 1995 Nov; 25(5):372-8. PubMed ID: 7674994
[TBL] [Abstract][Full Text] [Related]
35. Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
Cortes J; Fayad L; O'Brien S; Keating M; Kantarjian H
Clin Cancer Res; 1999 Sep; 5(9):2491-7. PubMed ID: 10499624
[TBL] [Abstract][Full Text] [Related]
36. Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group.
Oriol A; Vives S; Hernández-Rivas JM; Tormo M; Heras I; Rivas C; Bethencourt C; Moscardó F; Bueno J; Grande C; del Potro E; Guardia R; Brunet S; Bergua J; Bernal T; Moreno MJ; Calvo C; Bastida P; Feliu E; Ribera JM;
Haematologica; 2010 Apr; 95(4):589-96. PubMed ID: 20145276
[TBL] [Abstract][Full Text] [Related]
37. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.
Vilas-Zornoza A; Agirre X; Abizanda G; Moreno C; Segura V; De Martino Rodriguez A; José-Eneriz ES; Miranda E; Martín-Subero JI; Garate L; Blanco-Prieto MJ; García de Jalón JA; Rio P; Rifón J; Cigudosa JC; Martinez-Climent JA; Román-Gómez J; Calasanz MJ; Ribera JM; Prósper F
Leukemia; 2012 Jul; 26(7):1517-26. PubMed ID: 22307227
[TBL] [Abstract][Full Text] [Related]
38. [Prognosis and related factors of acute lymphoblastic leukemia].
Zhang W; Fu R; Liu WH; Cheng YQ; Song WX; DU LJ; Ruan EB; Zhang LT; Wang XM; Liang Y; Wang GJ; Qu W; Song J; Zhang RL; Guan J; Li LJ; Zou P; Shao ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1102-6. PubMed ID: 17956700
[TBL] [Abstract][Full Text] [Related]
39. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.
Fielding AK; Rowe JM; Buck G; Foroni L; Gerrard G; Litzow MR; Lazarus H; Luger SM; Marks DI; McMillan AK; Moorman AV; Patel B; Paietta E; Tallman MS; Goldstone AH
Blood; 2014 Feb; 123(6):843-50. PubMed ID: 24277073
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.
Marquard L; Gjerdrum LM; Christensen IJ; Jensen PB; Sehested M; Ralfkiaer E
Histopathology; 2008 Sep; 53(3):267-77. PubMed ID: 18671804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]